


Outsmarting complex diseases with more intelligent medicines



#DidYouSee - BioTuesdays featured our CEO, Timothy Lu! He discusses how the Company's Gene Circuit platform is advancing next-generation cell and gene therapies. Read More: bit.ly/4f7zCjo $SNTI #CellandGeneTherapy #Cancer

#StayInTheLoop Get the latest updates from Senti Bio delivered straight to your inbox. Sign up today: bit.ly/3ZVnb39 $SNTI #AML #Leukemia #Oncology



Don’t miss the latest from Senti Biosciences! Subscribe to email alerts for updates on our pipeline, research, and company news: bit.ly/3ZVnb39 $SNTI #Oncology #Leukemia

Our CEO, Tim Lu, highlighted a transformational milestone as positive FDA RMAT feedback advances SENTI-202 toward a potential registrational study in relapsed/refractory AML. Read more here: bit.ly/4wv4mCD $SNTI #AML #Oncology #CellTherapy

Our Chief Medical Officer, Kanya Rajangam, highlighted strong momentum for SENTI-202, supported by encouraging clinical activity, a favorable safety profile, and advancements in donor selection. Learn more: bit.ly/4wv4mCD $SNTI

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program bit.ly/4wv4mCD $SNTI

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase bit.ly/4dpqGFi $SNTI #CellTherapy #Oncology #AML


This #WorldDNADay, we recognize the power of genetic science in advancing new approaches to cancer treatment. At Senti Bio, we’re leveraging gene circuits to drive innovation in cell and gene therapy. $SNTI #Oncology #AML

On #AMLWorldAwarenessDay, we recognize the urgency to advance research and bring forward new therapies. Because behind every diagnosis is a life, a family, and a future. We acknowledge the importance of continuing to push science forward to create new possibilities for patients.

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026 bit.ly/3QgGnqb $SNTI #CellTherapy #Oncology #AML

Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies bit.ly/4cgkRue $SNTI #CellTherapy #Oncology #AML